A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)

NCT07636811 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Down Syndrome-Associated Alzheimer's Disease (DS-AD)

Interventions

DRUG: Mivelsiran
DRUG: Placebo

Sponsor

Alnylam Pharmaceuticals